Investigation of Carbonic Anhydrase Inhibition, Antioxidant Properties, and Selective Anticancer Activity of Methyl‐Substituted Halogenated and Methoxy Conduritols
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/5819417 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioMed Research International, online erschienen am 12.02.2026. Verfasst von Hayrani Eren Bostancı und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Turkey, cumhuriyet.edu.tr. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Antioxidants, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
This study aimed to investigate the anticancer, potential antiepileptic agents, and antioxidant potentials of 10 methyl‐substituted halogenated and methoxy conduritols, which had been previously synthesized and characterized. The presence of active functional groups within their structures suggested their potential as bioactive molecules. Both in vitro and in silico approaches were employed to assess their biological activities and therapeutic relevance.
Methods
Anticancer activity was tested using the MCF‐7 breast cancer cell line and the L929 fibroblast cell line, with IC 50 values calculated to evaluate cytotoxicity. Antioxidant activity was determined using DPPH, FRAP, and TAS assays. The effects of methyl‐substituted mono‐ and dimethoxy halogenated conduritol derivatives (A and B forms) on the activities of carbonic anhydrase isoenzymes hCA I and hCA II were examined spectrophotometrically. Additionally, molecular docking studies were performed against hCA I (PDB ID: 3LXE), hCA II (PDB ID: 5AML), and breast cancer proteins (PDB ID: 1JNX, 1A52). ADME/T properties of the compounds were also evaluated to predict their pharmacokinetic and safety profiles.
Results
Among the synthesized derivatives, only compound 6 demonstrated notable anticancer activity, with an IC₅₀ of 20.22 μ M against MCF‐7 cells and moderate selectivity over healthy fibroblasts. The other compounds were largely inactive at the tested concentrations. Antioxidant assays demonstrated considerable free radical scavenging and reducing power. The synthesized conduritols showed strong inhibition of carbonic anhydrase isoenzymes, with Ki values ranging from 0.2083 ± 0.11 to 1.4944 ± 1.06 μ M for hCA I and 0.0857 ± 0.06 to 2.2098 ± 0.68 μ M for hCA II, outperforming standard inhibitors. Docking studies confirmed strong binding affinities to the investigated proteins, while ADME/T analysis suggested favorable pharmacokinetic properties.
Conclusions
The findings indicate that methyl‐substituted halogenated and methoxy conduritols possess anticancer, potential antiepileptic agents, and antioxidant potentials. Their strong carbonic anhydrase inhibitory activities highlight their promise as potential therapeutic agents for epilepsy and glaucoma. Overall, these compounds demonstrate considerable potential as multifunctional bioactive molecules and represent promising candidates for further preclinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Sivas Cumhuriyet University, Sivas, Turkey, cumhuriyet.edu.tr.
- Department of Chemistry, Faculty of Sciences and Arts, Ordu University, Ordu, Turkey, odu.edu.tr.
- Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
- Plant and Animal Production Department, Technical Sciences Vocational School of Sivas, Sivas Cumhuriyet University, Sivas, Turkey, cumhuriyet.edu.tr.
ORCID-Profile: Hayrani Eren Bostancı, Ebrar Büşra Yıldırım, Feyza Nur Çetin, Ümit Muhammet Koçyiğit, Alireza Poustforoosh, Burak Tüzün, Latif Kelebekli
Zitieren
APA
Bostancı, H. E., Yıldırım, E. B., Çetin, F. N., Kaplan, D., Koçyiğit, Ü. M., Poustforoosh, A., Tüzün, B., & Kelebekli, L. (2026). Investigation of Carbonic Anhydrase Inhibition, Antioxidant Properties, and Selective Anticancer Activity of Methyl‐Substituted Halogenated and Methoxy Conduritols. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/5819417
Vancouver
Bostancı HE, Yıldırım EB, Çetin FN, Kaplan D, Koçyiğit ÜM, Poustforoosh A, et al. Investigation of Carbonic Anhydrase Inhibition, Antioxidant Properties, and Selective Anticancer Activity of Methyl‐Substituted Halogenated and Methoxy Conduritols. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/5819417
BibTeX
@article{Bostanc2026,
author = {Bostancı, Hayrani Eren and Yıldırım, Ebrar Büşra and Çetin, Feyza Nur and Kaplan, Dilek and Koçyiğit, Ümit Muhammet and Poustforoosh, Alireza and Tüzün, Burak and Kelebekli, Latif},
title = {Investigation of Carbonic Anhydrase Inhibition, Antioxidant Properties, and Selective Anticancer Activity of Methyl‐Substituted Halogenated and Methoxy Conduritols},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/5819417}
}
EUVIMED